BeStock  
Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3432BiotechnologyAI medical concept stocks
$11.47 −$0.94 (-7.57%)
Pre-market · Oct 8, 8:20 am ET · After hours $11.31 -1.40%
Open$11.81
Prev close$12.41
Day range$10.81 – $11.95
Volume6.46M
Market cap$772.39M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.7%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+14.7%
Worst reaction-30.5%

Stock move on the day after each report

-1.5%2023/Q1-12.9%2023/Q2-3.2%2023/Q3-5.5%2024/Q2+2.5%2024/Q3-11.5%2024/Q4+14.7%2025/Q1-8.7%2025/Q2-20.8%2025/Q3-30.5%2025/Q4-13.5%2026/Q1-9.3%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q25 Aug 2026After Market±15.7%-9.29%Within range
2026/Q17 May 2026After Market±16.6%-13.47%Within range
2025/Q426 Feb 2026After Market±20.4%-30.48%Bigger than priced
2025/Q36 Nov 2025After Market±18.8%-20.80%Bigger than priced
2025/Q27 Aug 2025After Market±20.6%-8.69%Within range
2025/Q16 May 2025After Market±23.8%+14.73%Within range
2024/Q425 Feb 2025After Market±30.7%-11.47%Within range
2024/Q312 Nov 2024After Market±23.1%+2.50%Within range
2024/Q28 Aug 2024After Market±101.5%-5.46%Within range
2023/Q38 Nov 2023Pre Market±30.1%-3.25%Within range
2023/Q29 Aug 2023After Market±21.4%-12.94%Within range
2023/Q110 May 2023Pre Market±26.5%-1.46%Within range
2022/Q41 Mar 2023After Market±30.1%+0.00%Within range
2022/Q314 Nov 2022After Market±25.6%-0.37%Within range
2022/Q215 Aug 2022After Market±21.5%+7.16%Within range
2022/Q116 May 2022After Market±25.5%+12.76%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$20.16M-48.5% YoY
Operating profit-$58.55M-7.2% YoY
Net profit-$46.71M+22.5% YoY
Diluted EPS-$0.75+31.8% YoY
Free cash flow-$46.89M-16.4% YoY
Operating cash flow-$44.27M

Revenue, last 8 quarters

$89.0MSep '24$43.8MDec '24$38.2MMar '25$39.1MJun '25$38.8MSep '25$33.4MDec '25$19.5MMar '26$20.2MJun '26

Net profit, last 8 quarters

$-56.4MSep '24$-107.5MDec '24$-91.0MMar '25$-60.3MJun '25$-80.8MSep '25$-80.8MDec '25$-82.6MMar '26$-46.7MJun '26

Profitability & balance sheet

Gross margin68.0%
Operating margin-228.6%
Net margin-219.6%
Return on equity-56.3%
Return on assets-26.2%
Return on invested capital-33.0%
Current ratio4.57
Liabilities / assets57.5%
Cash & investments$302.16M
Total debt$404.11M
Net cash (debt)-$101.95M

Discussion

No comments yet — be the first to weigh in on DNA.

Leave a comment

Scroll to Top